Block admission six monthly return

RNS Number : 9304D
Braveheart Investment Group plc
09 March 2022
 

9 March 2022

 

Braveheart Investment Group plc

(the "Company")

 

Block admission six monthly return

 

Braveheart Investment Group (AIM: BRH), announces the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies.

 

 

Name of company:

 

Braveheart Investment Group plc

Name of scheme:

 

Share options to directors, employees and consultants announced on 17 December 2020

 

Period of return:

 

From 9 September 2021 to 9 March 2022

Number and class of securities not issued under the scheme at the beginning of the period:

1,096,000 ordinary shares of 2 pence each in the Company (the "Ordinary Shares")

 

Number of securities issued under the scheme during the period:

 

Nil

 

Balance under the scheme of securities not yet issued at the end of the period:

 

1,096,000 Ordinary Shares

Number and class of securities originally admitted and the date of admission:

 

1,150,000 Ordinary Shares on 9 March 2021

Contact name and telephone number:

 

Trevor Brown, Chief Executive Officer

01738 587555

 

 

For further information:

 



Braveheart Investment Group plc

Tel: 01738 587555



Trevor Brown CEO




Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne




Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFLFEDVDIDIIF
UK 100

Latest directors dealings